Department of Health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older Follows recent approval from China’s National ...

By Amy Goodman & Denis Moynihan On Thursday, Human Rights Watch (HRW) issued a damning, 184-page report on this manufactured ...

As global markets navigate a landscape marked by rate cuts from the ECB and SNB, and with the U.S. Federal Reserve poised for another potential cut, small-cap stocks have faced challenges, evidenced ...

Union Minister for Road Transport and Highways, Nitin Gadkari, made this announcement stating its objective of improving last ...